Dark

Check out our Level2View

CNCE
Concert Pharmaceuticals, Inc.
stock NASDAQ

Inactive

Mar 3, 2023

8.37USD+0.120%(+0.01)10,733,298

Pre-market

0.00USD-100.000%(-8.36)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 4, 2022

07:05AM EST Concert Pharmaceuticals Completes Enrollment In THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 For Alopecia Areata Benzinga

Nov 9, 2021

12:08PM EST How Bad Are Concert Pharmaceuticals's Earnings? | Return On Capital Employed Benzinga

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:31AM EST Concert Pharmaceuticals Q3 EPS $(0.78) Beats $(0.81) Estimate, Sales $500.00K Down From $1.50M YoY Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 4, 2021

07:35AM EDT Concert Pharmaceuticals Announces $65M Financing Benzinga

07:00AM EDT Concert Pharmaceuticals Announces $65 Million Financing Business Wire

Nov 2, 2021

01:10PM EDT Concert Pharmaceuticals Granted U.S. Patent #11,161,798 '4-hydroxybutyric acid analogs' Benzinga

Oct 25, 2021

07:04AM EDT Concert Pharmaceuticals Completes Enrollment In THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 For Alopecia Areata Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

07:31AM EDT Mizuho Maintains Buy on Concert Pharmaceuticals, Lowers Price Target to $9 Benzinga

Sep 15, 2021

07:38AM EDT The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs Benzinga

Sep 13, 2021

09:42AM EDT Concert Pharmaceuticals Sponsored Study Titled 'European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata' Posted To ClinicalTrials.Gov Website; Study Not Yet Recruiting Benzinga

Aug 27, 2021

05:12PM EDT Looking into Concert Pharmaceuticals's Return on Capital Employed Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

07:20AM EDT Concert Pharmaceuticals Q2 EPS $0.16 Up From $(0.41) YoY, Sales $32.02M Up From $6.39M YoY Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 14, 2021

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jul 1, 2021

01:44PM EDT Concert Pharma Sees US Application Submission For Patchy Hair Loss Candidate In 2023 Benzinga

07:03AM EDT Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit Benzinga

May 27, 2021

07:01AM EDT Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 For Alopecia Areata Benzinga

May 18, 2021

06:43AM EDT Concert Pharma Sells VX-561-Related Milestones To Vertex For $32M Benzinga

May 17, 2021

04:08PM EDT Concert Pharmaceuticals Announces Sale of VX-561 Milestones to Vertex for $32M Benzinga

May 13, 2021

08:10AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use Benzinga

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

May 4, 2021

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

07:18AM EDT Concert Pharmaceuticals Q1 EPS $(0.67) Beats $(0.69) Estimate, Sales $5.00K Down From $7.00K YoY Benzinga

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 20, 2021

08:07AM EDT The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex Benzinga

Apr 19, 2021

10:18AM EDT Stocks That Hit 52-Week Lows On Monday Benzinga

Apr 13, 2021

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

Mar 26, 2021

07:28AM EDT The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs Benzinga

Mar 25, 2021

07:58AM EDT The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut Benzinga

Mar 24, 2021

08:59AM EDT The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping Benzinga

Feb 25, 2021

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

07:12AM EST Concert Pharmaceuticals Q4 EPS $(0.69) Beats $(0.78) Estimate, Sales $7.00K Down From $13.00K YoY Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 2, 2021

11:13AM EST Truist Securities Maintains Buy on Concert Pharmaceuticals, Lowers Price Target to $22 Benzinga

Feb 1, 2021

02:36PM EST Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Viela Bio Shares Spike Higher Benzinga

12:10PM EST Mid-Day Market Update: Silver Surges 7%; Concert Pharmaceuticals Shares Plunge Benzinga

10:15AM EST Shares of Concert Pharmaceuticals, Inc. (CNCE) are losing nearly 40% on Monday morning after the drug company said CTP-692 study in schizophrenia fails to meet primary or secondary endpoint. RTTNews

10:13AM EST Mid-Morning Market Update: Markets Open Higher; Thermo Fisher Scientific Tops Q4 Estimates Benzinga

07:02AM EST Concert Pharmaceuticals Announces CTP-692 Phase 2 Trial Did Not Achieve Primary Endpoint Assessing Positive and Negative Syndrome Scale Total Score At 12 Weeks Benzinga

Dec 16, 2020

11:25AM EST Benzinga's Top Upgrades, Downgrades For December 16, 2020 Benzinga

10:32AM EST Berenberg Initiates Coverage On Concert Pharmaceuticals with Buy Rating, Announces Price Target of $25 Benzinga

Nov 5, 2020

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

06:09AM EST Concert Pharmaceuticals Q3 EPS $(0.60) Beats $(0.75) Estimate Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 3, 2020

07:02AM EST Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata Benzinga

Nov 2, 2020

08:59AM EST Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 29, 2020

10:03AM EDT Concert Pharma Reports Will Present CTP-543 Data From Long-Term Extension Study In Alopecia Areata During Late-Breaking Session At European Academy Of Dermatology And Venereology Virtual Congress Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 13, 2020

07:01AM EDT Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtual Congress Benzinga

Sep 29, 2020

07:25AM EDT Concert Expects CTP-692 Phase 2 Topline Results In Q1 Of 2021; Completes Enrollment RTTNews

07:04AM EDT Concert Pharmaceuticals Completes Enrollment in CTP-692 Phase 2 Trial in Patients with Schizophrenia; CTP-692 Phase 2 Topline Results Expected First Quarter of 2021 Benzinga

Share